FdaApplication
NDA 014713
Identifiers
- fda_app_no: NDA014713
Properties
| Property | Value |
|---|---|
| applicant_name | SCHERING CORP SUB SCHERING PLOUGH CORP |
| application_type | NDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ETRAFON 2-10 | AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE | 10MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ETRAFON 2-25 | AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE | 25MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ETRAFON-A | AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE | 10MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ETRAFON-FORTE | AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE | 25MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
4 products